BLVRB anticorps (Middle Region)
-
- Antigène Voir toutes BLVRB Anticorps
- BLVRB (Flavin Reductase (BLVRB))
-
Épitope
- Middle Region
- Reactivité
- Humain, Souris, Rat, Cheval, Chien, Cobaye, Lapin, Boeuf (Vache)
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp BLVRB est non-conjugé
-
Application
- Western Blotting (WB)
- Séquence
- GLKYVAVMPP HIGDQPLTGA YTVTLDGRGP SRVISKHDLG HFMLRCLTTD
- Homologie
- Cow: 93%, Dog: 100%, Guinea Pig: 100%, Horse: 86%, Human: 100%, Mouse: 100%, Rabbit: 92%, Rat: 100%
- Attributs du produit
- This is a rabbit polyclonal antibody against BLVRB. It was validated on Western Blot using a cell lysate as a positive control.
- Purification
- Affinity Purified
- Immunogène
- The immunogen is a synthetic peptide directed towards the middle region of human BLVRB
- Top Product
- Discover our top product BLVRB Anticorps primaire
-
-
- Indications d'application
- Optimal working dilutions should be determined experimentally by the investigator.
- Commentaires
-
Antigen size: 206 AA
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Evaluating bone health in women with oestrogen receptor positive breast cancer (ERBC) starting aromatase inhibitors." dans: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, Vol. 35, Issue 5, pp. 475-80, (2009) (PubMed).
: "
-
Evaluating bone health in women with oestrogen receptor positive breast cancer (ERBC) starting aromatase inhibitors." dans: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, Vol. 35, Issue 5, pp. 475-80, (2009) (PubMed).
-
- Antigène
- BLVRB (Flavin Reductase (BLVRB))
- Autre désignation
- BLVRB (BLVRB Produits)
- Synonymes
- anticorps BVRB, anticorps FLR, anticorps SDR43U1, anticorps biliverdin reductase B (flavin reductase (NADPH)), anticorps biliverdin reductase B, anticorps Blvrb, anticorps BLVRB
- Sujet
-
BLVRB catalyzes electron transfer from reduced pyridine nucleotides to flavins as well as methylene blue, pyrroloquinoline quinone, riboflavin, or methemoglobin. BLVRB has possible role in protecting cells from oxidative damage or in regulating iron metabolism. In the liver, BLVRB converts biliverdin to bilirubin.
Alias Symbols: BVRB, FLR, MGC117413, SDR43U1
Protein Interaction Partner: SUMO1, NEDD8, UBC, RPL31, ORM1, GMDS, HMOX1,
Protein Size: 206 - Poids moléculaire
- 22 kDa
- ID gène
- 645
- NCBI Accession
- NM_000713, NP_000704
- UniProt
- P30043
-